Cite
HARVARD Citation
von Spee-Mayer, C. et al. (2016). Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus. Annals of the rheumatic diseases. 75 (7), pp. 1407-1415. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
von Spee-Mayer, C. et al. (2016). Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus. Annals of the rheumatic diseases. 75 (7), pp. 1407-1415. [Online].